Login / Signup

Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma.

Zhi-Ming WangShi-Long ZhangHua YangRong-Yuan ZhuangXi GuoHan-Xing TongYong ZhangWei-Qi LuYu-Hong Zhou
Published in: Cancer medicine (2020)
High-dose anlotinib combined with epirubicin was an effective and safe therapy for STS.
Keyphrases
  • high dose
  • low dose
  • stem cell transplantation
  • endothelial cells
  • vascular endothelial growth factor
  • cell therapy
  • wound healing
  • stem cells
  • mesenchymal stem cells